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levels in the Mongolian population
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Abstract
Background: Abnormalities in lipid metabolism are crucial factors in the pathogenesis of cardiovascular disease
(CVD). Variants of many genes have been verified to confer risk for lipid metabolism abnormalities. However, the
relationship between genetic variants of the NCC-encoding SLC12A3 gene and lipid metabolism in the Mongolian
population remains unclear. In the present study, we aimed to elucidate the effects of SLC12A3 variants on Mongolian
lipid metabolism, including total cholesterol (TCHO), triglycerides (TG), low-density lipoprotein cholesterol (LDL-c), and
high-density lipoprotein cholesterol (HDL-c).
Methods: A randomly selected population of Mongolians (n = 331) from China underwent clinical testing. An ANOVA
test, Kruskal-Wallis H test (K-W test) and haplotype analysis were used to evaluate the association between the levels of
lipids (TCHO, TG, LDL-c, and HDL-c) and polymorphisms in SLC12A3 loci.
Results: We identified three single nucleotide polymorphisms (SNPs) rs5803, rs2010501 and rs711746 in the SLC12A3
gene that were significantly associated with an individual’s serum LDL-c level. Haplotypes combining these SNPs also
showed the same trend (all p values < 0.01). Furthermore, the influence of SLC12A3 genetic polymorphisms on
differences in individual serum LDL-c levels remained significant, even after we controlled gender, and demographic
and other non-genetic factors.
Conclusion: These results suggest that variants of the SLC12A3 gene confer susceptibility to the abnormal serum LDL-c
level in the Mongolian population.
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Background
Serum lipid and lipoprotein concentrations are tightly
associated with cardiovascular disease (CVD), which is
the major leading cause of death and disability world-
wide [1]. Abnormalities in lipid metabolism, such as in-
creased levels of triglycerides (TG) and low-density
lipoprotein cholesterol(LDL-c), and decreased levels of
high-density lipoprotein cholesterol(HDL-c), have been
identified to be crucial factors to the pathogenesis of
CVD [2, 3]. Many well-designed studies have clearly
established LDL-c as the major target for lipid-
modifying therapy [4] because elevated LDL-c is a major
contributor to CVD [5, 6].
Serum lipid levels are also modulated by genetic [7, 8]
and multiple environmental risk factors [9, 10] and their
interactions [11, 12]. Approximately 50% of serum lipid
abnormalities can be explained by genetic variants [13].
For instance, Chen et al. [14] proposed that there was a
close relationship between the MTHFR gene and the
longevity of a cohort in Bama, a well-known home of
longevity in China, and that T allele carriers had a
modestly unfavorable impact on lipid levels (i.e., higher
LDL-c level) with a gender difference. Sone et al. [15]
discovered that the genetic variants of the FADS gene
are associated with LDL-c level in Japanese males, and
Cuevas et al. [16] suggested the HMGCR rs17671591
polymorphism as a genetic marker of lower LDL-c after
atorvastatin therapy in the Chilean population.
In addition to genetic predisposition, epidemiological
risk factors also play crucial roles in the abnormalities of
lipid profiles, including, 1) gender differences, a com-
mon feature in an individual’s serum lipid levels, and 2)
body mass index (BMI, weight in kilograms divided by
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height in square meters). Garcia-Palmieri et al. [17]
stated that diet and relative weight could account for up
to 6% of the variability in serum cholesterol levels. To be
more specific, for every 1-kg decrease in body weight,
TG decreased by 0.011 mmol/L and HDL-c increased by
0.011 mmol/L [18]; 3) Lifestyle (e.g., smoking, alcohol
consumption, etc.) has also been shown to influence
serum lipid levels. Rimm et al. [19] documented that
consuming 30 g of ethanol per day increased the con-
centrations of HDL-c by 3.99 mg/dL, and TG by
5.69 mg/dL; Yin et al. [11, 20] also showed that BMI,
cigarette smoking and alcohol consumption could inter-
act with certain lipid-related gene variants to modify the
serum lipid levels in BaiKu Yao and Han Chinese ethnic
groups.
Mongolian is one of the ethnic groups in China with a
high prevalence of hypertension and lipid abnormalities.
Family aggregation of the diseases in Mongolians sug-
gests that the genetic factor might play an important
role in the etiology of these diseases in Mongolians. The
genetic basis of lipid abnormality is complex; therefore,
it is a huge challenge for us to certify those true suscep-
tible genes/loci to lipid abnormality. Carrying out associ-
ation studies in some population with different
evolutionary history and linkage disequilbrium (LD),
such as minor ethnic groups, may further narrow these
regions to identify the causal gene(s) and is helpful for
the identification of functional variants of complex
diseases.
Our previous studies demonstrated the association of
SLC12A3 gene variants with Mongolian hypertension
[21–23] and meanwhile we also found that the levels of
TC [21], TG [21–23] and LDL-c [21, 23] are significantly
increased, whereas that of HDL-c [21] is slightly de-
creased in Mongolian hypertension when compared with
Mongolian normotensives. Thus, it is possible that the
genetic polymorphisms of SLC12A3 might be associated
with hypertension via modulating an individual’s serum
lipid levels. This possibility was tested on a randomly se-
lected population of Mongolians (n = 331) from China
and at the present study we aimed to clarify the associ-
ation of SLC12A3 variants with lipid profiles and the
mechanisms underlying lipid abnormality in Mongolians
and provide the scientific basis for the prevention and
treatment of this complex disease.
Methods
Subjects
We tested 331 unrelated, randomly selected adult resi-
dents (59.81% female, mean age = 45 ± 12.17 years (range
20–70 years old)) in the Inner Mongolia Autonomous
Region of China, including Dongwuzhumuqin County,
Xianghuang County, and the city of Xilinhot. All sub-
jects were of Mongolian ethnic origins. Written
informed consents were obtained from all participants.
The study was performed in accordance with the Declar-
ation of Helsinki and was approved by the Ethical Com-
mittee of Affiliated Hospital of Inner Mongolia Medical
University.
Demographic information and serum lipid parameters
Demographic variables collected in this study included
age, gender, smoking status and drinking status. A
smoker was defined as smoking at least one cigarette per
day for at least 1 year, and smoking status was catego-
rized into never (76.44%) and current (20.24%) sub-
groups. Alcohol consumption was defined as current
status (20.54%), consuming 50 mL or more alcohol per
day for at least 1 year. Participants’ heart rate, or pulse,
was measured as the number heart beats per minute.
Subjects’ height and weight were measured, body mass
index (BMI) was calculated as weight (kg) divided by the
square of height (m), and waist-hip ratio (WHR) was
assessed by dividing waistline (cm) by hipline (cm). Nor-
mal weight, overweight, moderate obesity, and severe
obesity were defined by BMI and WHR indexes accord-
ing to WHO recommendations.
Blood samples were obtained from the antecubital vein
after ≥8 h of fasting. Part of the collected samples were
used to determine serum lipid levels and another part
were transferred into a tube with anti-coagulate solution
and used to extract deoxyribonucleic acid (DNA). To
profile individuals’ serum lipid status, four important pa-
rameters, TCHO, TG, HDL-c, and LDL-c were measured
within 8 h, using routine methods in the local hospital.
Fasting blood glucose was tested using a Dollar general
glucose meter (Dollar, Korea). Genomic DNA was iso-
lated from peripheral blood leukocytes using an
AxyPrep-96 DNA Extraction Kit (Axygen, Union City,
CA, USA).
Tag SNPs and genotyping
To minimize the genotyping load while maximizing as-
sociation information, the implementation of haplotype-
tagging SNP (tSNP) selection was performed using the
HAPLOVIEW 4.2 software package, using the method
described by Gabriel et al.[24]. Fifteen SNPs of the
SLC12A3 gene were chosen from HCB_Asian population
data in the HapMap SNP set (version 22) (http://hap-
map.ncbi.nlm.nih.gov/) based on pairwise r2 ≥ 0.5 and
minor allele frequency (MAF) ≥ 0.05.
The genotyping was performed as described previously
[22]. In brief, 1) the target DNA sequences were ampli-
fied using a multiplex PCR method in a final volume of
10 μl; 2) thermal cycling was performed for all SNPs loci
in Gene Amp PCR system 9600 (PerkinElmer, Waltham,
MA, USA); and 3) the fluorescent products of ligase
detection reaction were differentiated by Applied
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Biosystems 3730 DNA Analyzer (Applied Biosystems,
CA, USA). To verify the accuracy of the genotyping re-
sults for tagSNPs, we randomly sequenced 20 samples.
Statistical analysis
PASW statistics 18 (formerly SPSS Statistics; http://
www.spss.com.hk/statistics) was used to analyze the
data. The Hardy-Weinberg equilibrium (HWE) testing
was calculated using the Finetti method (https://
ihg.gsf.de/cgi-bin/hw/hwa2.pl), and the gender differ-
ences for alleles and genotypes’ distributions were also
evaluated. All variables were categorized by the median
value in study sample and t-tests were performed to esti-
mate the effects of non-genetic variables on individuals’
serum lipid levels. A one-way analysis of variance
(ANOVA) and LSD post hoc test were performed to
examine the influence of each tagSNP on individual
serum lipid status (including TCHO, TG, HDL-c and
LDL-c). The non-parametric test, Kruskal-Wallis H test
(K-W test) was also used. Linkage condition and haplo-
types construction of positive SNPs were estimated by
UNPHASED software (version 3.0.13) [25]. More strin-
gent criteria for positive tag SNP(s) was adopted: tag
SNP(s) which demonstrated a significant association
using both ANOVA and the K-W test were considered.
To partial out other non-genetic variables (i.e., age,
gender, BMI, and WHR) that might have influences on
the relationship between SNPs and individuals’ serum
lipid status, a multiple regression analysis was performed
in which the genotype group served as one of the class
variables. For the multiple linear regression analysis, we
performed the following steps: (step 1) entering control
variable(s) and (step 2) entering both variables and the
genetic information. The statistical power analysis was
referred to as p < 0.05 for two-tailed tests.
Results
Demographic characteristics and serum lipid levels
The general characteristics of subjects and their relation-
ship with individuals’ serum lipid levels were presented
in Table 1. Comparison tests found that serum lipid pro-
files were correlated with several environmental factors,
including age, gender, alcohol consumption, cigarette
smoking, blood glucose, BMI and WHR (p < 0.05–
0.001). Older subjects (>45 years) showed a significantly
higher serum level of TG than that of younger subjects
(≤ 45 years) (1.98 ± 2.42 vs.1.51 ± 1.26, p < 0.05). Men
had higher serum levels of TCHO, TG and LDL-c than
women (all ps < 0.01–0.001). Smokers also had higher
serum levels of LDL-c than never smokers (3.52 ± 1.37,
p < 0.01). Alcohol consumption also exhibited signifi-
cantly higher serum levels of TCHO, TG and LDL-c
than never drinkers (all p values < 0.05–0.01). The sub-
jects with higher glucose levels in blood had extremely
higher serum levels of TCHO, HDL-c, LDL-c (all p
values < 0.001), and higher levels of TG (p < 0.05) than
those with normal glucose. Lower heart rate per minute
also showed a weak influence on individuals’ TCHO and
HDL-c levels (all p values < 0.05). Over-weight and obes-
ity (BMI > 25.2 kg/m2, or WHR > 0.88) often yielded sig-
nificantly higher levels of TG and HDL-c (all p values <
0.05–0.001), whereas normal BMI was associated with a
significantly high HDL-c level (p < 0.001).
Genotyping and distribution analysis
Genotype frequencies of all 15 SNPs showed no signifi-
cant deviations from Hardy – Weinberg equilibrium
(WHE), except rs2289119 and rs7204044 (X2 = 3.92, p =
0.048, and X2 = 7.27, p = 0.007, respectively). And no
gender difference distributions of alleles and genotypes
frequency were found. The genotyping success rates for
all SNPs were higher than 96.98% (321/331).
Genetic variants effects on TCHO, TG, HDL-c and LDL-c
Table 2 presented data of the genetic variants of the
SLC12A3 gene on individuals’ serum lipid profile.
Rs5803 polymorphisms showed a significant association
with individuals’ serum level of LDL-c (F = 3.881, p =
0.022 for ANOVA, and X2 = 7.378, p = 0.025 for K-W
test), the T allele carriers had higher LDL-c levels than
CC genotype carriers (3.32 ± 1.38 mmol/L vs.2.93 ±
1.25 mmol/L). Both rs2010501 and rs711746 had a close
association with individuals’ serum TCHO and LDL-c
levels (all ps < 0.01). Interestingly, when dominant gen-
etic models (carriers of rare allele vs. dominant allele
homozygous) were performed for all SNPs, the results
demonstrated the same trend.
To confirm the above analyses, we also derived the
predicted probabilities of being single for different ge-
notypes from the linear regression equation, after con-
trolling other variables. Finally, the association between
rs5803, rs2010501, rs711746 and individuals’ serum
level of LDL-c was found to still be significant, even
with other variables controlled (B = -0.044, Error SD =
0.018, t = -2.490, p = 0.014 for rs5803, B = 0.048, Error
SD = 0.018, t = 2.653, p = 0.009 for rs2010501, and B =
0.040, Error SD = 0.017, t = 2.350, p = 0.020 for
rs711746). The T allele of rs5803 had a negative associ-
ation with individuals’ elevated serum level of LDL-c,
whereas the T allele of rs2010501 and A allele of
rs711746 with a positive association. The genetic poly-
morphisms of three SNPs contributed more than 11.9%
variation of individual’s serum LDL-c level difference
(R2 change > 0.119, and Sig. of F change < 0.001, for
both SNPs). Additionally, individuals’ levels of blood
glucose were found to have an extremely significant ef-
fect (all ps < 0.001).
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Haplotype analysis for positive SNPs
The linkage disequilibrium among the three positive
SNPs was estimated by UNPHASED software, and a
strong linkage disequilibrium between rs2010501 and
rs711746 (D’ = 0.97, r2 = 0.44) was observed. We con-
structed three sets of haplotypes. Two were derived from
various combinations of two SNPs (two window size),
and one was derived from a combination of all three
SNPs (three window size). Three sets of haplotypes dis-
played significant additive genetic influences on individ-
ual’s serum LDL-c levels in both two and three windows
analyses (all global p values < 0.001). Several individual
haplotypes, constructed by two or three SNP sites,
demonstrated significant genetic effects on individuals’
serum LDL-c levels, compared with the first haplotypes
(all p values < 0.05–0.001) (Table 3).
Discussion
In this study, we investigated the influence of genetic
polymorphisms in the SLC12A3 gene on human serum
lipid levels (TCHO, TG, HDL-c and LDL-c), within a
randomly selected Mongolian cohort in China. Our data
demonstrated that three SNPs, rs5803, rs2010501 and
rs711746 of 15 tag SNPs in the SLC12A3 gene were sig-
nificantly associated with individuals’ serum levels of
LDL-c. Haplotypes combining with these SNPs also
Table 1 Effects of demographic, lifestyle characteristics and other non-genetic factors on individuals’ serum lipid levels
Variables a n TCHO (mmol/L) TG (mmol/L) HDL-c (mmol/L) LDL-c (mmol/L)
Age (years)
≤ 45 171 4.76 ± 1.77 1.51 ± 1.26 1.49 ± 0.58 3.01 ± 1.32
> 45 160 5.08 ± 2.06 1.98 ± 2.42* 1.43 ± 0.55 3.25 ± 1.33
Sex
Male 139 5.17 ± 1.89*** 2.00 ± 2.00** 1.45 ± 0.58 3.34 ± 1.34**
Female 192 4.67 ± 1.71 1.58 ± 1.36 1.45 ± 0.47 2.98 ± 1.28
Smoker
Never 253 4.85 ± 1.92 1.68 ± 2.03 1.47 ± 0.54 3.05 ± 1.30
Smoker 67 5.31 ± 1.96 1.95 ± 1.49 1.47 ± 0.66 3.52 ± 1.37**
Unknown 11 - - - -
Drink
Never 241 4.75 ± 1.76 1.59 ± 1.43 1.44 ± 0.53 3.03 ± 1.30
Drinker 68 5.63 ± 2.44** 2.39 ± 3.17** 1.55 ± 0.74 3.54 ± 1.44*
Unknown 22 - - - -
Blood_G (mg/ml)
≤5.7 160 4.38 ± 1.71 1.50 ± 2.10 1.32 ± 0.47 2.79 ± 1.16
>5.7 147 5.47 ± 2.00*** 1.99 ± 1.67* 1.61 ± 0.65*** 3.44 ± 1.39***
Unknown 24 - - - -
Heart_R (min−1)
≤ 76 143 5.28 ± 2.11* 1.85 ± 2.25 1.58 ± 0.65* 3.30 ± 1.37
> 76 122 4.75 ± 1.89 1.72 ± 1.65 1.41 ± 0.54 3.07 ± 1.32
Unknown 66 - - - -
BMI (kg/m2)
≤ 24.44 166 4.84 ± 1.95 1.40 ± 1.20 1.60 ± 0.63*** 2.91 ± 1.35
> 24.44 162 4.97 ± 1.91 2.07 ± 2.39** 1.32 ± 0.47 3.33 ± 1.27**
Unknown 3 - - - -
WHR
≤ 0.87 132 4.82 ± 2.07 1.40 ± 1.20 1.54 ± 0.68 3.00 ± 1.35
> 0.87 128 5.23 ± 2.00 2.27 ± 2.53*** 1.42 ± 0.54 3.36 ± 1.36*
Unknown 71 - - - -
*** p value < 0.001; ** p value < 0.01; * p value < 0.05
Abbreviation BMI body mass index, WHR waist-hip ratio, Blood_G fasting blood glucose in serum, Heart_R heart rate per minute, TCHO total cholesterol (mmol/L),
TG triglycerides (mmol/L), HDL-C high-density lipoprotein cholesterol (mmol/L), LDL-C low-density lipoprotein cholesterol (mmol/L)
aall variables were categorized by the median value in study sample
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showed the same trend. Furthermore, the influence of
SLC12A3 genetic polymorphisms on the differences
observed in individual serum LDL-c levels remained
significant, even after we controlled demographic,
gender and other non-genetic factors. To the best of
our knowledge, this study is the first to demonstrate
the influence of genetic variants in SLC12A3 on hu-
man serum level of LDL-c.
LDL-c plays a pivotal role in CVD, while the associ-
ation between elevated serum LDL-c level and hyperten-
sion remains unclear [26–28]. We observed an elevated
serum LDL-c level in hypertensive patients [21, 23]
when we investigated the association between genetic
variants of SLC12A3 and hypertensive patients in Mon-
golians in China. The results from this randomly se-
lected Mongolian sample were consistent with our
Table 3 Effects of haplotypes constructed by three positive SNPs on LDL-c levels
Haplotypes a Frequency (%) AddVal 95%Lo 95%Hi Chisq p b Global p b
rs5803(T/C)-rs2010501(C/T)
T-T 22.43 −0.044 −0.042 0.335 4.927 0.026 2.23e-4
C-C 18.65 −0.448 −0.852 −0.043 14.03 1.80e-4
C-T 55.25 −0.105 −0.453 0.243 1.002 0.317
rs2010501(C/T)-rs711746(G/A)
C-G 21.81 - - - 10.56 1.15e-3 7.68e-4
T-G 16.16 0.145 −0.065 0.355 0.734 0.391
T-A 61.65 0.291 0.128 0.453 12.56 3.95e-4
rs5803(T/C)-rs2010501(C/T)-rs711746(G/A)
T-T-A 21.90 −0.050 −0.502 0.402 4.521 0.033 5.76e-4
C-C-G 18.61 −0.426 −0.898 0.045 12.43 4.22e-4
C-T-G 15.40 −0.224 −0.627 0.180 0.967 0.325
C-T-A 39.52 −0.062 −0.509 0.386 3.035 0.812
Abbreviation: Fre. is the frequencies of risk haplotypes, AddVal the estimated additive genetic value relative to the reference haplotype, 95% Lo 95% lower
confidence limit for the additive value, 95% Hi 95% upper confidence limit for the additive value
aThe haplotypes frequencies < 0.05 were excluded in global p-value calculation
bBold type denotes p < 0.05
Table 2 Effects of SNPs on individuals’ serum lipid levels
SNPs a Variables Genotypes/Mean (SD) ANOVA K-W
F p b Chi2 p b
rs5803 TT(25) TC(126) CC(177)
TCHO 4.67 ± 1.80 5.21 ± 1.93 4.72 ± 1.93 2.591 0.076 6.536 0.038
TG 1.59 ± 1.41 1.77 ± 1.48 1.72 ± 2.25 0.098 0.907 4.247 0.120
HDL-c 1.49 ± 0.60 1.53 ± 0.57 1.42 ± 0.55 1.470 0.231 4.256 0.119
LDL-c 3.10 ± 1.41 3.36 ± 1.38 2.93 ± 1.25 3.881 0.022 7.378 0.025
rs2010501 CC(16) CT(110) TT(195)
TCHO 4.07 ± 1.28 4.70 ± 1.97 5.12 ± 1.94 3.390 0.035 7.014 0.030
TG 1.07 ± 0.66 1.64 ± 2.51 1.86 ± 1.62 1.492 0.227 13.604 0.001
HDL-c 1.35 ± 0.54 1.45 ± 0.59 1.50 ± 0.56 0.620 0.538 1.690 0.430
LDL-c 2.49 ± 0.86 2.87 ± 1.28 3.31 ± 1.37 5.868 0.003 11.173 0.004
rs711746 GG(48) GA(148) AA(125)
TCHO 4.14 ± 1.17 5.00 ± 2.01 5.14 ± 2.04 4.910 0.008 7.553 0.023
TG 1.18 ± 0.48 1.83 ± 2.38 1.87 ± 1.61 2.444 0.088 11.284 0.004
HDL-c 1.37 ± 0.48 1.49 ± 0.59 1.50 ± 0.57 1.020 0.362 2.177 0.337
LDL-c 2.55 ± 0.85 3.10 ± 1.35 3.35 ± 1.42 6.333 0.002 9.911 0.007
Abbreviation: TCHO total cholesterol (mmol/L), TG triglyceride (mmol/L), HDL-c high-density lipoprotein cholesterol (mmol/L), LDL-c low-density lipoprotein cholesterol
(mmol/L), ANOVA one-way analysis of variance, K-W Kruskal-Wallis H test
aSNPs, at least one positive association between individuals’ serum levels presented, were shown analyzed by both ANOVA and K-W tests
bBold type denotes p < 0.05
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hypothesis that SLC12A3 polymorphisms may modulate
serum LDL-c level and represent a close relationship
with hypertensive patients that have been reported pre-
viously [22, 23]. Two SNPs (rs5803 and rs711746), which
were reportedly associated with hypertension in case-
control and family-based association studies, also
showed significant influences on individuals’ serum
LDL-c level in the general Mongolian population. Col-
lectively, these results demonstrated the important
modulation effect of SLC13A gene on human serum
LDL-c levels and their observed association with
hypertension.
Demographic and lifestyle characteristics also showed
a close relation with serum LDL-c levels, in addition to
its genetic association. In the present population, several
non-genetic variables, including gender, smoking status,
alcohol consumption, fasting blood glucose, BMI and
WHR, all contributed to differences in individuals’
serum levels of LDL-c (Table 2). Meanwhile, gender dif-
ference may play an important role and should be con-
sidered further in future experiments. Lifestyle factors,
including smoking status and alcohol consumption re-
vealed an extreme difference between males and females.
Males also demonstrated higher BMI and WHR indexes
than females (data not shown). However, when we used
linear regression analysis to estimate each variable’s in-
fluence on individuals’ LDL-c level, the impact of blood
glucose concentration on LDL-c was observed, whereas
the influence from other variables disappeared, except
for the three genetic variants of SLC12A3. Hsu and Fava
et al. [29, 30] also suspected that SLC12A3 polymor-
phisms might regulate individuals’ blood pressure via af-
fecting their fasting plasma glucose concentrations.
One should be cautious when interpreting these find-
ings given the following limitations. We examined the
influence of genetic polymorphisms in the SLC12A3
gene on human LDL-c level status within a specific
population. The high prevalence of hypertension is a ser-
ious health problem among Mongolian people [31], as
CVD is a primary cause of morbidity and mortality [32].
Genetic influences of the SLC12A3 gene on LDL-c levels
were revealed in this population. Second, the limited
sample size should also be carefully noted, despite the
statistical power analyses showing a satisfied estimation
value. For some rare homozygous alleles, the sample size
still seemed insufficient, especially when we partialed
out subjects with missing variables. Third, several char-
acteristics and lifestyle information were included in this
study. These characteristics are susceptible to change,
and it is not clear whether the association between the
SLC12A3 and LDL-c level would still hold. It may be the
case that under certain circumstances, the genetic con-
tribution to LDL-c level could be overshadowed by other
factors. In addition, to avoid false association a double-
measure was performed in our study, that is, the associ-
ation between polymorphisms of SLC12A3 and lipid me-
tabolism will be considered, only when both the
parametric (ANOVA) and non-parametric (KW) ana-
lyses results were supportive and consistent. However,
we couldn’t rule out the impact of SLC12A3 on individ-
ual’s TCHO and TG levels, although it did not show a
consistent correlation, completely.
Conclusion
Our results concluded that variants of the SLC12A3 gene
confer susceptibility to the abnormal serum LDL-c levels
in the Mongolian population.
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